Kömüves L G, Hanley K, Jiang Y, Elias P M, Williams M L, Feingold K R
Department of Dermatology, University of California, San Francisco, USA.
J Invest Dermatol. 1998 Sep;111(3):429-33. doi: 10.1046/j.1523-1747.1998.00296.x.
Because a protective barrier is essential for life, the development of the epidermis and stratum corneum must be completed prior to birth. The epidermal permeability barrier is comprised of corneocytes embedded in a lipid enriched matrix. Recent studies from our laboratory, using an explant model of fetal rat skin development that closely parallels in utero development, have shown that hormones and other activators of members of the nuclear receptor family regulate permeability barrier ontogenesis by stimulating lipid metabolism and the formation of the extracellular lipid lamellae. Using this model we sought to determine whether these hormones and nuclear activators also regulate keratinocyte differentiation during fetal development. Profilaggrin/filaggrin and loricrin expression, assessed by in situ hybridization and by immunohistochemistry, were progressively increased during epidermal ontogenesis. Whereas profilaggrin/filaggrin and loricrin were not expressed at day 17 of gestation, by day 19 both were present in the upper layers of the epidermis and both became still more abundant by day 21. These developmental changes also occurred in fetal skin explants cultured in vitro for 4 d, although the expression levels did not appear as robust as in utero. Whereas neither profilaggrin/filaggrin nor loricrin were expressed in control explants cultured for 2 d, they were seen in explants treated with either thyroid hormone, glucocorticoids, or estrogens. In contrast, dihydrotestosterone treatment delayed the expression of profilaggrin/filaggrin and loricrin. Moreover, both clofibrate, a peroxisome proliferator-activated receptor-alpha ligand, and juvenile hormone III, a farnesoid X-activated receptor activator, markedly accelerated fetal epidermal differentiation, stimulating both profilaggrin/filaggrin and loricrin expression. Our results demonstrate that several hormones and activators of nuclear hormone receptors regulate epidermal differentiation during fetal development, affecting key constituents of both keratohyalin granules and the cornified envelope. Thus, a variety of ligands/activators of nuclear receptors accelerate not only permeability barrier ontogenesis, but also the expression of structural proteins essential for stratum corneum formation.
由于保护屏障对生命至关重要,表皮和角质层的发育必须在出生前完成。表皮渗透屏障由嵌入富含脂质基质中的角质形成细胞组成。我们实验室最近利用与子宫内发育密切相似的胎鼠皮肤发育外植体模型进行的研究表明,激素和核受体家族成员的其他激活剂通过刺激脂质代谢和细胞外脂质层的形成来调节渗透屏障的发生。利用这个模型,我们试图确定这些激素和核激活剂在胎儿发育过程中是否也调节角质形成细胞的分化。通过原位杂交和免疫组织化学评估,前丝聚合蛋白/丝聚合蛋白和兜甲蛋白的表达在表皮发生过程中逐渐增加。虽然在妊娠第17天未表达前丝聚合蛋白/丝聚合蛋白和兜甲蛋白,但到第19天两者都出现在表皮上层,并且到第21天两者都变得更加丰富。这些发育变化也发生在体外培养4天的胎儿皮肤外植体中,尽管表达水平似乎不如子宫内那样强劲。在培养2天的对照外植体中,前丝聚合蛋白/丝聚合蛋白和兜甲蛋白均未表达,但在用甲状腺激素、糖皮质激素或雌激素处理的外植体中可见它们的表达。相反,双氢睾酮处理延迟了前丝聚合蛋白/丝聚合蛋白和兜甲蛋白的表达。此外,过氧化物酶体增殖物激活受体-α配体氯贝丁酯和法尼醇X激活受体激活剂保幼激素III均显著加速胎儿表皮分化,刺激前丝聚合蛋白/丝聚合蛋白和兜甲蛋白的表达。我们的结果表明,几种激素和核激素受体激活剂在胎儿发育过程中调节表皮分化,影响透明角质颗粒和角质包膜的关键成分。因此,多种核受体配体/激活剂不仅加速渗透屏障的发生,而且加速角质层形成所必需的结构蛋白的表达。